CorMedix Insider Acquires Shares
A CorMedix insider recently acquired company shares valued at approximately $390,000, as disclosed in a recent SEC filing.
Stocks · News reference
Cormedix (NASDAQ:CRMD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
A CorMedix insider recently acquired company shares valued at approximately $390,000, as disclosed in a recent SEC filing.
Filed: 2026-11-16 AccNo: 0001213900-26-120016 Size: 350 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Following the company's third-quarter earnings report, analysts from Oppenheimer and RBC adjusted their price targets for CorMedix while maintaining positive ratings.
Major M&A deals this week include: CorMedix buys Heron for $145M and Craveworthy Brands buys New England Authentic Eats.
CorMedix announced its financial results for the third quarter ended September 30, 2026, reporting $54.5 million in consolidated revenue and a net loss of $14.7 million.